Fig. 3From: Exosomal miR-105-5p derived from bladder cancer stem cells targets for GPR12 to promote the malignancy of bladder cancerInhibition of miR-105-5p reversed the carcinogenic effects of CSCs-exo. AÂ The expression levels of miR-105-5p in CSCs, T24 and EJ cells were measured by RT-qPCR. BÂ The expression levels of miR-105-5p were measured in EJ and T24 cells after incubated with CSCs-exo. CÂ miR-105-5p inhibitor was transfected into CSCs, and CSCs-exo. DÂ Cell viability, E and FÂ migration and GÂ invasion of EJ and T24 cells were determined after incubation with CSCs-exo. Experiments were conducted thrice for each approach. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. CSCs Cancer stem cells, CSCs-exo Exosomes derived from cancer stem cellsBack to article page